Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel adjunctive therapy for refractory partial seizures
2007-006168-31Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2008
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of perampanel in epilepsy and Focal Onset Epilepsy (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Percent change in seizure frequency per 28 days. Started May 2008; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2007-006168-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006168-31.